Immunosuppresion clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression
Sorry, not yet accepting patients
The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix vaccination rates at VA facilities. The main question[s] it aims to answer is: Will vaccination rates improve more rapidly for facilities with access to the dashboard compare to facilities without access? VA facility personnel will be granted access to the dashboard and outcomes (vaccination rates) will be measured using electronic health record data.
Our lead scientists for Immunosuppresion research studies include Gabriela Schmajuk, MD MS.
Last updated: